CITI PHARMA, a leading pharmaceutical company headquartered in Pakistan, has established itself as a key player in the healthcare industry since its inception in 1994. With a strong operational presence across various regions, the company focuses on the development, manufacturing, and marketing of high-quality pharmaceutical products. CITI PHARMA is renowned for its diverse portfolio, which includes prescription medications, over-the-counter products, and specialised formulations. The company’s commitment to innovation and quality has earned it a reputable position in the market, marked by several key milestones in research and development. With a dedication to improving patient outcomes, CITI PHARMA continues to expand its reach and enhance its product offerings, solidifying its status as a trusted name in the pharmaceutical sector.
How does CITI PHARMA's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
CITI PHARMA's score of 22 is lower than 83% of the industry. This can give you a sense of how well the company is doing compared to its peers.
CITI PHARMA, headquartered in Pakistan (PK), currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Consequently, there are no documented Scope 1, 2, or 3 emissions to analyse. In terms of climate commitments, CITI PHARMA has not established any formal reduction targets or initiatives, nor does it participate in recognised frameworks such as the Science Based Targets initiative (SBTi). The company has not made any public climate pledges or commitments to reduce its carbon footprint. As there is no available emissions data or reduction initiatives, CITI PHARMA's current climate strategy remains unclear. The company may benefit from developing a comprehensive sustainability plan to address potential environmental impacts and align with industry standards.
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
CITI PHARMA is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.